Inhibition of TGF-β-receptor signaling augments the antitumor function of ROR1-specific CAR T-cells against triple-negative breast cancer
Tanja Stüber(Universitätsklinikum Würzburg), Michael Hudecek(Lighthouse Guild)
Cited by 142
Related Papers
The Nonsignaling Extracellular Spacer Domain of Chimeric Antigen Receptors Is Decisive for <i>In Vivo</i> Antitumor Activity
|Cancer Immunology Research|2014|517
ROR1-CAR T cells are effective against lung and breast cancer in advanced microphysiologic 3D tumor models
|JCI Insight|2019|192
Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)–an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT)
|Bone Marrow Transplantation|2019|119